The time to cure hepatitis B is now
Last year nearly 900 000 people died from the disease. An international consortium of scientists, also from DZIF, is calling for increased investments in HBV cure research and cure preparedness.
A helper with foresight
Christoph Lange was recently appointed as Medical Director of the Research Center Borstel. From here, he substantially contributes to clinical tuberculosis research in Europe, also monitoring the development and treatment of multidrug-resistant cases. Learn more about his work.
Disparities in treatment of multidrug-resistant tuberculosis across Europe
Scientists have shown that multidrug-resistant tuberculosis care in Eastern Europe is markedly worse in than in Western Europe.
Doctor and data guru at the DZIF
Jörg Janne Vehreschild is senior physician at the Department of Internal Medicine in Cologne and on a DZIF professorship where is responsible for HIV research cohorts. Learn more about his work.
18 September 2018 - PRESS RELEASE
A DZIF research team has achieved a breakthrough: the diagnosis of multi-resistant hospital pathogens is now possible in less than an hour.
[ more ]
12 September 2018 - CALL FOR APPLICATION
11 September 2018 - PRESS RELEASE
DZIF e. V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL email@example.com